यूरोपीय संघ - स्वीडिश - EMA (European Medicines Agency)

novartis europharm ltd - glycopyrronium bromid - pulmonell sjukdom, kronisk obstruktiv - läkemedel mot obstruktiv lungsjukdom, - enurev breezhaler är indicerat som en underhållsbronkodilatorbehandling för att lindra symtomen hos vuxna patienter med kronisk obstruktiv lungsjukdom (kol).

यूरोपीय संघ - स्वीडिश - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformin hydroklorid - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

यूरोपीय संघ - स्वीडिश - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - diabetes mellitus, typ 2 - läkemedel som används vid diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

यूरोपीय संघ - स्वीडिश - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformin hydroklorid - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 och 5. 1 för tillgänglig data på olika kombinationer).

यूरोपीय संघ - स्वीडिश - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - diabetes mellitus, typ 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 och 5. 1 för tillgänglig data på olika kombinationer).

यूरोपीय संघ - स्वीडिश - EMA (European Medicines Agency)

novartis europharm limited - ranibizumab - wet macular degeneration; macular edema; diabetes complications; myopia, degenerative; choroidal neovascularization - ögonsjukdomar - lucentis är indicerat hos vuxna för behandling av neovaskulära (våt) åldersrelaterad makuladegeneration (amd)behandling av synnedsättning på grund av koroidal kärlnybildning (cnv)behandling av nedsatt syn på grund av diabetiska makulaödem ödem (dme)behandling av nedsatt syn på grund av makulaödem ödem sekundärt till retinal vein occlusion (branch rvo eller centrala rvo).

यूरोपीय संघ - स्वीडिश - EMA (European Medicines Agency)

novartis europharm limited - glycopyrronium bromid - pulmonell sjukdom, kronisk obstruktiv - läkemedel mot obstruktiv lungsjukdom, - seebri breezhaler är indicerat som en underhållsbronkodilatorbehandling för att lindra symtom hos vuxna patienter med kronisk obstruktiv lungsjukdom (kol).

यूरोपीय संघ - स्वीडिश - EMA (European Medicines Agency)

novartis europharm limited  - vildagliptin, metformin hydroklorid - diabetes mellitus, typ 2 - läkemedel som används vid diabetes - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

यूरोपीय संघ - स्वीडिश - EMA (European Medicines Agency)

novartis europharm limited - omalizumab - asthma; urticaria - läkemedel mot obstruktiv lungsjukdom, - allergiska asthmaxolair är indicerat hos vuxna, ungdomar och barn (6 till.

यूरोपीय संघ - स्वीडिश - EMA (European Medicines Agency)

novartis europharm limited - rivastigmin - alzheimer disease; parkinson disease; dementia - psychoanaleptics, - symtomatisk behandling av mild till måttligt svår alzheimers demens. symtomatisk behandling av mild till måttligt svår demens hos patienter med idiopatisk parkinsons sjukdom.